Sign In
Create Account
Forgot Password?
Google Play
App Store
Save
Featured
Webinars
Events
eLearning & CME
Topics
Industry portal
Journals
Open access
Search
Loading
Navbar input
WAIT FOR SUGGESTIONS BY CATEGORY
OR CONTINUE TYPING IN YOUR KEYWORDS
ENTER ONE OR MULTIPLE KEYWORDS &
PRESS THE SEARCH BUTTON
From
To
Search
Favorites
Advanced
Minimize
More ▾
Less ▸
Clear
Protected by US Patents
For full functionality of this site it is necessary to enable JavaScript. Here are the
instructions how to enable JavaScript in your web browser
.
PB0289 Association of Elevated Coagulation Factors VIII, IX and XI with Recurrent Thrombotic Events in Children with Non-Central Venous Line Deep Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407230
PB0290 Bleeding Complications in Children with Myeloproliferative Neoplasms and Thrombosis on Anticoagulation
ISTH Academy, Faculty / Presenters, 407231
PB0291 Clinical Manifestations, Treatment and Outcomes of Pediatric Portal Vein Thrombosis
ISTH Academy, Faculty / Presenters, 407232
PB0292 Thrombotic Risk Evaluation in Pediatric Patients with Acute Lymphoblastic Leukemia Using Thrombin Generation Test
ISTH Academy, Faculty / Presenters, 407233
PB0287 Thromboembolic and Hemorrhagic Events in Pediatric Patients Assisted with Mechanical Circulatory Support and Bivalirudin Anticoagulation: A Retrospective Observational Study
ISTH Academy, Faculty / Presenters, 407234
PB0281 Establishment of a National Patient-Based Pediatric Thrombosis Registry by Iranian Society of Thrombosis and Hemostasis
ISTH Academy, Faculty / Presenters, 407235
PB0286 Population Pharmacokinetics and Pharmacodynamics of Bivalirudin in Children on Ventricular Assist Device Support
ISTH Academy, Faculty / Presenters, 407236
PB0282 Evaluation of Plasma Coagulative and Fibrinolytic Function in Critically Ill Children with COVID-19 or MIS-C An Analysis of the COVAC-TP Trial
ISTH Academy, Faculty / Presenters, 407237
PB0283 Impact of An Institutional Anticoagulant Thromboprophylaxis Protocol in Hospitalized Pediatric Patients with Inflammatory Bowel Disease at High Risk for Venous Thromboembolism
ISTH Academy, Faculty / Presenters, 407238
PB0284 Resolution Rates of Provoked Venous Thrombus Embolism in Pediatric Patients Managed at a Tertiary Care Center
ISTH Academy, Faculty / Presenters, 407239
PB0285 Use of Systemic Thrombolysis in Pediatric Cardiac-Related Thrombosis; A Retrospective Cohort Study
ISTH Academy, Faculty / Presenters, 407240
PB0279 Intermediate- and High-Risk Pulmonary Embolism in Pediatric Tertiary Care Centers in the Netherlands. Is there a need for a Pediatric PERT?
ISTH Academy, Faculty / Presenters, 407241
PB0277 Outcomes of Cerebrosinovenous Thrombosis in Infants and Children
ISTH Academy, Faculty / Presenters, 407242
PB0278 Pediatric Renal Tumors: Clinical Outcomes in Patients with and without Tumor-Related Thrombus
ISTH Academy, Faculty / Presenters, 407243
PB1355 Long Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Case Report
ISTH Academy, Faculty / Presenters, 407244
PB1352 A Survey on Anticoagulation in Patient with ITP
ISTH Academy, Faculty / Presenters, 407245
PB1349 Clinical Relevance and Management of Bleeding in Patients with Myelodysplastic Syndromes and Severe Thrombotytopenia: A Retrospective Analysis
ISTH Academy, Faculty / Presenters, 407246
PB1351 High-Doses of Dexamethasone as an Alternative to Other Steroidal Use in Primary Immune Thrombocytopenia Cases: A Research Study in a Salvadoran Population
ISTH Academy, Faculty / Presenters, 407247
PB1346 A New Canine Thrombopoietin Assay Reveals Common Pathogenesis of Canine and Human Immune Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407248
PB1347 Evaluating Local Practice Patterns and IVIg Use to Treat Immune Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407249
PB1348 Thrombopoietin Receptor Agonist and Rituximab Combination Therapy in Patients with Refractory Primary Immune Thrombocytopenia. A Single-Center Study
ISTH Academy, Faculty / Presenters, 407250
PB1345 Health-Related Quality of Life Assessed by the SF-36 Health Survey in the Vienna ITP Biobank
ISTH Academy, Faculty / Presenters, 407251
PB1342 Clinical Significance of Anti-Nuclear Antibody Positivity in Immune Thrombocytopenia Purpura in Adults
ISTH Academy, Faculty / Presenters, 407252
PB1344 Impact of Spleen Tyrosine Kinase Inhibition on Vaccine-Induced Thrombotic Thrombocytopenia Antibody-Induced Procoagulant Platelet and Thrombus Formation
ISTH Academy, Faculty / Presenters, 407253
PB1341 Obinutuzumab-Induced Thrombocytopenia: An Under-Recognized Immunotherapy Related Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407254
PB1336 Novel Insight into Platelet Refractoriness: Desialylation, Apoptosis and Treatment
ISTH Academy, Faculty / Presenters, 407255
PB1338 Thrombotic Thrombocytopenia Syndrome after vaccination against COVID-19 Associated with Antiplatelet Antibodies
ISTH Academy, Faculty / Presenters, 407256
PB1332 Heightened Thrombosis in Immune Thrombocytopenia: Insights into the Risk Factors and Clinical Outcomes from an Australian Hospital Cohort
ISTH Academy, Faculty / Presenters, 407257
PB1334 Safety Profile of Efgartigimod from Clinical Trials in Participants with Immunoglobulin G-Mediated Autoimmune Diseases
ISTH Academy, Faculty / Presenters, 407258
PB0337 Occult Cervical Cancer-Induced Refractory Thrombotic Thrombocytopenic Purpura in a Renal Transplant Patient with Low- level Cytomegalovirus Viremia: A Case Report
ISTH Academy, Faculty / Presenters, 407259
PB0336 Refractory Thrombotic Thrombocytopenic Purpura Treated by Discontinuation of Therapeutic Plasma Exchange
ISTH Academy, Faculty / Presenters, 407260
PB0334 Immune-Mediated Thrombotic Thrombocytopenic Purpura Landscaping in Gulf Countries: A Real-World Evidence Study (ATHENA Study)
ISTH Academy, Faculty / Presenters, 407261
PB0335 Medical Education in Congenital Thrombotic Thrombocytopenic Purpura Significantly Improves Competence in Making Appropriate Management Choices
ISTH Academy, Faculty / Presenters, 407262
PB0332 Hereditary Thrombotic Thrombocytopenic Purpura: A Survey of Canadian Treaters
ISTH Academy, Faculty / Presenters, 407263
PB0333 Therapeutic Plasma Exchange-Related Complications in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
ISTH Academy, Faculty / Presenters, 407264
PB0330 Relevance of ADAMTS13 Antigenic Levels in the Characterization of Pathological Mechanisms Associated with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP)
ISTH Academy, Faculty / Presenters, 407265
PB0327 Modulating ADAMTS13 Activity Using Organic Solvents
ISTH Academy, Faculty / Presenters, 407266
PB0328 Outcomes of Immune-Mediated Thrombotic Thrombocytopenic Purpura at a Single Center in Japan
ISTH Academy, Faculty / Presenters, 407267
PB0324 Burden of Symptoms and Healthcare Resource Utilization (HCRU) and Costs in U.S. Patients with Thrombotic Thrombocytopenic Purpura (TTP)
ISTH Academy, Faculty / Presenters, 407268
PB0325 How Rare is Rare? The First Epidemiological Study of Thrombotic Thrombocytopenic Purpura (TTP) in a Large Canadian City
ISTH Academy, Faculty / Presenters, 407269
PB0326 Incidence of Thrombotic Thrombocytopenic Purpura and Other Suspected Thrombotic Microangiopathies during the COVID-19 Pandemic Period 2020-2021 in Quebec
ISTH Academy, Faculty / Presenters, 407270
PB0322 Burden of Illness Associated with Congenital Thrombotic Thrombocytopenic Purpura: A Systematic Review
ISTH Academy, Faculty / Presenters, 407271
PB0323 Preliminary Analysis of ATHN 16: Real-World Safety of Eptacog Beta
ISTH Academy, Faculty / Presenters, 407272
PB0321 Prospective Evaluation of the HemosIL AcuStar ADAMTS13 Activity Assay
ISTH Academy, Faculty / Presenters, 407273
PB0318 Evaluation of a Novel ADAMTS13 Activity Reagent Using Fully Automated Analyzer
ISTH Academy, Faculty / Presenters, 407274
PB0319 Overexpression of ANKRD26 Results in Thrombocytopenia That May Exacerbate Clinical Phenotypes of Thrombotic Thrombocytopenic Purpura
ISTH Academy, Faculty / Presenters, 407275
PB0320 Understanding the Contribution of Single Synonymous Variants to ADAMTS13 Functionality
ISTH Academy, Faculty / Presenters, 407276
PB0316 Bortezomib for the Treatment of Multi-Refractory Immune-Mediated Thrombotic Thrombocytopenic Purpura: An Italian Multicenter Survey
ISTH Academy, Faculty / Presenters, 407277
PB0315 Characterizing Protease-Resistant ADAMTS13 Mutants
ISTH Academy, Faculty / Presenters, 407278
PB0317 Novel Luminescent-Based ADAMTS13 Activity Assay
ISTH Academy, Faculty / Presenters, 407279
PB0314 Treatment Delay and Outcomes in Elderly TTP Patients: A Nationwide Analysis
ISTH Academy, Faculty / Presenters, 407280
PB0312 Assessment of Post-Treatment Anti-Drug Antibodies to Caplacizumab in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura
ISTH Academy, Faculty / Presenters, 407281
PB0313 Towards the Standardisation of ADAMTS-13 Antibody Testing in Thrombotic Thrombocytopenic Purpura (TTP)-Results of the IMATAS Collaborative Study
ISTH Academy, Faculty / Presenters, 407282
PB0338 The Ideal Acetylsalicylic Acid (ASA) Dose to Combine with P2Y12 Inhibitors: A Volunteer Study
ISTH Academy, Faculty / Presenters, 407283
PB0354 Use of Intraoperative Heparin in Combination with Cangrelor in Patients with Acute Heparin-Induced Thrombocytopenia Undergoing Cardiopulmonary Bypass for Heart Transplantation: A Case Series
ISTH Academy, Faculty / Presenters, 407284
PB0353 Flow Cytometry Detection of Procoagulant Platelets: A Diagnostic Test for Heparin Induced Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407285
PB0352 Non-Pathogenic Anti-PF4 Antibodies after SARS-CoV-2 Vaccines: Long Term Follow-Up
ISTH Academy, Faculty / Presenters, 407286
PB0351 Complement Activating Properties of Heparin Induced Thrombocytopenia (HIT) Antibodies as Surrogate Markers for Functional Assays
ISTH Academy, Faculty / Presenters, 407287
PB0349 Anti-PF4-Antibodies in Patients Suspected of Vaccine-Induced Immune Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination
ISTH Academy, Faculty / Presenters, 407288
PB0350 Prospective Study to Evaluate the Consolidated Performance of Two Automated Rapid Assays for the Diagnosis of Heparin-Induced Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407289
PB0348 Can 5B9, a Monoclonal Antibody to PF4/H, be Useful in Improving the Performance of the Asserachrom HPIA Test for the Diagnosis of HIT?
ISTH Academy, Faculty / Presenters, 407290
PB0347 Argatroban or Bivalirudin for Suspected or Confirmed Heparin Induced Thrombocytopenia at a Large Academic Medical Center
ISTH Academy, Faculty / Presenters, 407291
PB0346 Monoclonal Gammopathy of Thrombotic/Thrombocytopenic Significance
ISTH Academy, Faculty / Presenters, 407292
PB0345 Diagnosing Heparin-Induced Thrombocytopenia: A Prospective Multicentre Study
ISTH Academy, Faculty / Presenters, 407293
PB0343 Longitudinal Study on the Persistence of Anti-Platelet Factor 4 Antibodies in Vaccine-Induced Immune Thrombotic Thrombocytopenia after 14 Months
ISTH Academy, Faculty / Presenters, 407294
PB0344 The Impact of Spleen Tyrosine Kinase-Inhibition on 5B9 HIT Antibody-Induced Procoagulant Platelet Formation
ISTH Academy, Faculty / Presenters, 407295
PB0342 Platelet Phosphatidylserine is the Critical Mediator of Thrombosis in Heparin-Induced Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407296
PB0805 Comparison of Three ELISA Assays for the Detection and Quantification of Autoantibodies against Complement Factor H
ISTH Academy, Faculty / Presenters, 407297
PB0804 Eculizumab Use in the Postpartum Period for the Treatment of Pregnancy Associated Atypical Hemolytic Uremic Syndrome: Retrospective Cohort Study
ISTH Academy, Faculty / Presenters, 407298
PB0358 Hereditary Bleeding Disorders Web-Based Registry of Patients with Inherited Platelet Disorders
ISTH Academy, Faculty / Presenters, 407299
PB0357 Hereditary Thrombocytopenia with Platelet Sialic Acid Deficiency and Mutations in the GNE Genes
ISTH Academy, Faculty / Presenters, 407300
PB0356 Results of Local Implementation of Next Generation Sequencing (NGS) for Diagnosis of Inherited Thrombocytopenias (IT) in Argentina
ISTH Academy, Faculty / Presenters, 407301
PB0355 Knock-in of Homozygous NBEAL2 Variants to Model Gray Platelet Syndrome in Megakaryocytes Derived from CRISPR-Cas9-edited Pluripotent Stem Cells
ISTH Academy, Faculty / Presenters, 407302
PB0363 A Case Report of Quinine-Induced Thrombotic Microangiopathy Treated with Eculizumab
ISTH Academy, Faculty / Presenters, 407303
PB0362 Atypical Hemolytic Uremic Syndrome after SARS-CoV2 Infection with C3 p.I1157 T Mutation
ISTH Academy, Faculty / Presenters, 407304
PB0367 Heavy Menstrual Bleeding in Paediatric Patient due to Resistant Chronic Immune Thrombocytopenia Successfully Treated with Eltrombopag and Tranexemic Acid - a Case Report Form Bosnia and Herzegovina
ISTH Academy, Faculty / Presenters, 407305
PB0366 Ticagrelor Overdose Managed without Adverse Outcomes: Is Reversal Agent Necessary?
ISTH Academy, Faculty / Presenters, 407306
PB0365 A Novel and Potent Collagen Antagonist, Niclosamide in Human Platelets: In Vitro and In Vivo Studies
ISTH Academy, Faculty / Presenters, 407307
PB0364 Glycoprotein VI-Targeted Antiplatelet Therapy with Glenzocimab is Safe in Patients Exposed to Current Antithrombotic and Fibrinolytic Drugs
ISTH Academy, Faculty / Presenters, 407308
PB1371 Platelet Activation with the Aeson Bioprosthetic Total Artificial Heart: Insight from Aspirin Treatment and Outcomes
ISTH Academy, Faculty / Presenters, 407309
PB1368 Platelet Subpopulations in Decompensated Cirrhotic Children
ISTH Academy, Faculty / Presenters, 407310
PB1369 Relevance of the Absence of Integrin αIIb Expression by Flow Cytometry in Acquired Glanzmann's Thrombasthenia
ISTH Academy, Faculty / Presenters, 407311
PB1370 Thrombocytosis and Acquired Bleeding Disorders in Patients with Myeloproliferative Neoplasms
ISTH Academy, Faculty / Presenters, 407312
PB1366 Characteristics of Platelets in Elderly Patients with Immune Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407313
PB1367 Pilot Study of microRNA (mir148a) Identification as a Biomarker for Early Diagnosis and Treatment of Heparin Induced Thrombocytopenia (HIT)
ISTH Academy, Faculty / Presenters, 407314
PB1365 Serum Complement Levels in Adult Patients with Primary Immune Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407315
PB1362 Fibrinogen Contribution to Clot Strength in Septic Patients with Hematologic Malignancies and Thrombocytopenia
ISTH Academy, Faculty / Presenters, 407316
PB1364 Study to Explore the Mechanisms of Platelet Function Abnormalities in Patients with Acquired Platelet Dysfunction with Eosinophilia (APDE) Utilising Flow Cytometry-Based Platelet Function Tests
ISTH Academy, Faculty / Presenters, 407317
PB1359 Fc Modified KKO Blocks Thrombosis in Heparin-Induced Thrombocytopenia (HIT), But not in Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
ISTH Academy, Faculty / Presenters, 407318
PB1360 High Annualized Bleeding Rates in Pediatric Patients with Mild Inherited Platelet Function Defects (IPFD)
ISTH Academy, Faculty / Presenters, 407319
PB1357 Addition of Platelet Factor 4 in the Heparin-Induced Platelet Activation (HIPA) Test for the Diagnosis of Heparin Induced Thrombocytopenia (HIT): Results from a Restrospective Monocentric Study
ISTH Academy, Faculty / Presenters, 407320
PB1358 Platelet Function Testing in Patients with Liver Cirrhosis and TIPS Implantation
ISTH Academy, Faculty / Presenters, 407321
PB1356 Intrinsic Platelet Dysfunction in Patients with Acute Intracerebral Hemorrhage
ISTH Academy, Faculty / Presenters, 407322
PB1396 Successful Hip Replacements in a Glanzmann Thrombasthenia Patient with Anti-Platelet Antibodies and Platelet- Refractory Disease Using rFVIIa: A Case Report
ISTH Academy, Faculty / Presenters, 407323
PB1395 Successful Management of Multiple Tooth Extraction in a Patient with Glanzmann Thrombasthenia with Platelet Antibodies
ISTH Academy, Faculty / Presenters, 407324
PB1392 Late Diagnosis of Two Adult Siblings with Bernard Soulier Syndrome (BSS)
ISTH Academy, Faculty / Presenters, 407325
PB1393 Living with Glanzmann's Thrombasthenia: An Interim Report on 14 Qualitative Interviews from the Glanzmann's 360 Study
ISTH Academy, Faculty / Presenters, 407326
PB1390 Gray Platelet Syndrome- Novel NBEAL2 Pathogenic Variants and Hemostasis Evaluation by Global Coagulation Assays
ISTH Academy, Faculty / Presenters, 407327
PB1391 Inherited δ- Granule Defect as a Novel Mutation Co-Existing with Factor VII Deficiency - Hermansky Pudlak Syndrome (HPS) Type 2
ISTH Academy, Faculty / Presenters, 407328
PB1385 Developing a Stem Cell-Based Model for Glanzmann Thrombasthenia to Explore VWF-GPIb Axis during Megakaryopoeisis
ISTH Academy, Faculty / Presenters, 407329
«
...
5
6
7
8
9
10
11
12
13
...
»